ArticlePediatrics international : official journal of the Japan Pediatric Society
Infection prevention in patients with inborn errors of immunity: Insights from Japan's nationwide study.
Article in Pediatrics international : official journal of the Japan Pediatric Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Infection prevention in patients with inborn errors of immunity: Insights from Japan's nationwide study.Pediatrics international : official journal of the Japan Pediatric SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundDifferences in infection prevention methods and their corresponding effects on patients with inborn errors of immunity (IEI) between departments that treat patients with IEI and other departments, such as local hospitals, are not known.
methodsWe compared the differences in infection prevention methods between low-volume departments (treating fewer than 20 patients with IEI) and high-volume departments (treating 20 or more patients with IEI) using recent nationwide survey data from Japan.
resultsThere was an uneven distribution of IEI categories between low- and high-volume departments. High-volume departments have set higher target trough levels for immunoglobulin replacement therapy in patients with BTK deficiency and those who have undergone transplantation. Furthermore, sulfamethoxazole-trimethoprim and itraconazole were used more frequently in high-volume departments for patients with hyper-IgE syndrome. Additionally, more patients with common variable immunodeficiency in high-volume departments received inactivated vaccines, whereas low-volume departments used macrolides more frequently than prophylactic antibiotics. Overall, infection prevention management appeared to be relatively similar in low- and high-volume departments. However, there were some notable differences in the specific practices.
conclusionsThe latest and most optimal infection control methods must be shared with every department where patients with IEI are treated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.